Introduction {#s1}
============

Pathogenic bacteria cause a multitude of deadly human diseases. Many of these microbes possess flagella, molecular machines responsible for cell motility, adherence to host cells, and pathogenicity ([@bib14]; [@bib21]). Flagella are helix-shaped hollow attachments formed predominantly by thousands of copies of the protein flagellin (also called FliC), anchored in the bacterial membrane by a hook (or joint) that is attached to the basal body and that is composed of rotary motor proteins ([@bib5]). A proton motive force typically drives the propeller motion of flagella ([@bib6]), resulting in swimming motility. A FliD (also called HAP2) oligomer forms the cap protein complex that is located at the tip of the flagellar filament ([@bib63]). This complex controls the distal growth of the filament by regulating the assembly of FliC molecules, which are transported through the hollow filament from the cytoplasm to the tip of the flagellum.

The dynamic movement of FliD in this assembly was modeled based on low (\~26 Å)-resolution cryo-electron microscopic (EM) structures of the *Salmonella* serovar Typhimurium flagellum-cap complex ([@bib38]; [@bib63], [@bib64]), which adopts the shape of a five-legged stool with flexible leg domains that regulate the assembly of new FliC molecules onto the tip of the growing flagellum ([@bib38]). It has been suggested that the plate of the stool is formed by core regions of the FliD molecule, and that disordered/flexible regions form the five leg structures ([@bib58]) that are known to interact with the FliC filament. FliD exhibits low sequence similarity to the flagellar hook proteins and to FliC. Nevertheless, it shares the disordered terminal regions of these flagellar proteins, a common structural characteristic that is thought to control the polymerization of flagellar proteins and to play an important role in interaction with the FliC filament ([@bib58]). These regions are the most conserved in FliD sequences across bacteria. Flagellum-mediated motility is crucial for the virulence and pathogenicity of numerous bacteria, including *Campylobacter jejuni* ([@bib8]), *Salmonella* ([@bib2]; [@bib39]), *Escherichia coli* ([@bib33]), *Vibrio cholera* ([@bib31]), and *Pseudomonas aeruginosa* ([@bib4]), as well as the major causative agent of gastric cancer *Helicobacter pylori* ([@bib29]). To date, however, no high-resolution structure of any FliD protein exists. To better define the roles of FliD in bacterial motility and pathogenesis, we determined the first X-ray crystal structure of FliD at 2.2 Å resolution, and assessed the structural contributions of its flexible regions using a multitude of complementary biophysical and functional analyses.

Results {#s2}
=======

Crystal structure of the FliD protein from *P. aeruginosa* PAO1 {#s2-1}
---------------------------------------------------------------

To facilitate crystallization of FliD from the *P. aeruginosa* PAO1 strain, we deleted the predicted coiled-coil domains on both the N- and C-termini of full length FliD, which has 474 residues (FliD~1--474~), to generate the truncated FliD~78-405~ ([Figure 1a](#fig1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). We expressed FliD~78--405~ in *E. coli* with an N-terminal His~6~-tag and purified it to homogeneity by Ni^2+^-NTA, size exclusion and anion exchange chromatography. We improved initially weakly diffracting crystals of FliD~78--405~ by random matrix microseed screening ([@bib7]), yielding crystals that diffracted to 2.2 Å resolution. In the absence of any homologous protein that could be used as a model for molecular replacement, we crystallized a seleno-methionine derivative of FliD~78--405~ that included four leucine-to-methionine mutations (FliD~78--405~/L~4~--M~4~). This crystal provided phase information sufficient to build an initial model, which we used subsequently for molecular replacement with the native FliD~78--405~ dataset ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). We modeled residues 80--273 into clear electron density, including all side chains, but observed density of increasingly poor quality in the C-terminus beyond residue 273 ([Figure 1---figure supplement 2a](#fig1s2){ref-type="fig"}). Thus, we were able to model with confidence only a single α helix in this region, corresponding to residues 274--308, with incomplete side chain structures. To determine whether the remaining region of the protein actually existed in the crystals and not just in the protein preparation used for crystallization, we analyzed crystals using liquid chromatography-mass spectrometry (LC-MS) and SDS-PAGE. Both analyses indicated that the crystals consisted of an approximate 50:50 mixture of the FliD~78--405~ protein used for crystallization and a further proteolyzed version with a molecular weight of about 27 kDa. The N-terminal His~6~-tag is still detectable by Western blot ([Figure 1---figure supplement 2b](#fig1s2){ref-type="fig"}). Thus, the proteolyzed form corresponds approximately to residues 78--319 of FliD. The 86 residues absent from the C-terminus in a population of FliD proteins are clearly not required for crystal packing, suggesting that they are highly flexible even in a crystalline environment.10.7554/eLife.18857.003Figure 1.Crystal structure of *Pseudomonas* FliD reveals structural similarity to other flagellar proteins.(**a**) Schematic representation of the FliD proteins used in these studies. Protein domain/region boundaries are labeled and are drawn approximately to scale. (**b**) Crystal structure of the *Pseudomonas* FliD~78--405~ monomer subunit with spectrum coloring from the N-terminus (blue) to the C-terminus (red). Head domain 1, head domain 2 and the leg region are indicated. (**c**) Superposition of the FliD~78--405~ crystal structure (domain coloring as in panel (a)) and *Burkholderia* FlgK/HAP1/hook filament capping protein (cyan). (**d**) Superposition of the FliD~78--405~ crystal structure (domain coloring as in panel (a)) and *Pseudomonas* flagellin/FliC (magenta).**DOI:** [http://dx.doi.org/10.7554/eLife.18857.003](10.7554/eLife.18857.003)10.7554/eLife.18857.004Figure 1---source data 1.Crystallographic data collection, phasing and refinement statistics.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.004](10.7554/eLife.18857.004)10.7554/eLife.18857.005Figure 1---figure supplement 1.Protein sequence of FliD~1--474~.The protein sequence of FliD from *P. aeruginosa* PAO1 is shown. The tertiary domain structure based on the presented X-ray crystal structure and the predicted secondary structure is indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.005](10.7554/eLife.18857.005)10.7554/eLife.18857.006Figure 1---figure supplement 2.Electron density and protein degradation of FliD crystals.(**a**) The overall electron density observed in the crystal structure of FliD is shown. Close-up views of representative residues in the head 1, head 2 and leg regions reveal low-quality and missing side-chain density in the leg region in comparison to the well-structured head domains. (**b**) SDS-PAGE (lane 1) and anti-His~6~-horseradish peroxidase (lane 2) Western blot analysis reveal C-terminal degradation of FliD~78--405~ in crystals. LC-MS analysis indicates the presence of the native FliD~78--405~ protein and degradation products in crystals of FliD~78--405~.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.006](10.7554/eLife.18857.006)

FliD is structurally similar on the domain level to FliC and FlgK {#s2-2}
-----------------------------------------------------------------

Our crystal structure of FliD~78--405~ reveals that it consists of two discreet regions with distinct conformational properties, corresponding to a stable head region and a flexible and/or disordered leg region ([Figure 1b](#fig1){ref-type="fig"}). The head region is itself comprised of two separate, but entwined, protein domains. Residues 80--101 form two β strands that belong to the first domain (Head 1), the second domain (Head 2) is formed in its entirety by the contiguous residues 104--230, and residues 231--273 then complete the first domain. The second domain is, thus, a loop insertion of the first domain. We searched for structural homologs of these domains in the Protein Data Bank and found that the first domain of the head region (Head 1) exhibits high structural similarity (RMSD=2.5 Å), despite low sequence identity (14%), to the FlgK/HAP1/hook filament capping protein of *Burkholderia pseudomallei* (PDB code 4UT1; [Figure 1c](#fig1){ref-type="fig"}). Likewise, the second head region domain (Head 2) exhibits high structural similarity (RMSD=2.7 Å), despite low sequence identity (17%), to the FliC/flagellin protein of *P. aeruginosa* (PDB code 4NX9; [Figure 1d](#fig1){ref-type="fig"}). In contrast to the head region, the leg region of FliD is highly flexible, as indicated by the paucity of electron density corresponding to residues 274--405 ([Figure 1---figure supplement 2a](#fig1s2){ref-type="fig"}). Despite this, we were able to model the initial α helical structural element, corresponding to residues 274--308, of this region. This helix extends from the axis of the head region at a nearly perpendicular angle, resulting in an L-shaped monomer subunit structure ([Figure 1b](#fig1){ref-type="fig"}).

FliD from *P. aeruginosa* PAO1 forms a hexamer {#s2-3}
----------------------------------------------

In the crystal, FliD~78--405~ monomer subunits are arranged in hexamers, resulting in a shape akin to a six-pointed star when viewed from the top of the FliD oligomer ([Figure 2a](#fig2){ref-type="fig"}), which corresponds to the distal end of the growing flagellum. This star shape has a minimum inner diameter of 48 Å and a maximal outer diameter of 136 Å. When viewed from the side ([Figure 2b](#fig2){ref-type="fig"}), the FliD hexamer appears as a six-legged stool, the legs of which extend 55 Å below the bottom of the head region. Additional crystallographic symmetry results in the stacking of hexamers in alternating head-to-head and leg-to-leg orientations ([Figure 2c](#fig2){ref-type="fig"}). The leg-to-leg stacking forms dodecamers, resulting from the helix--helix interaction of the residues 274--302 of stacked molecules and the interaction of residues 303--308 of one FliD~78--405~ molecule with Head 1 domain of a stacked molecule, burying a surface area of 1362 Å^2^. The formation of dodecamers may be unique to the FliD~78--405~ fragment, as this strand could potentially be replaced by additional N-terminal residues in the full-length FliD~1--474~ protein. All of the morphologies observed for *Pseudomonas* FliD are highly reminiscent of the pentamer/decamer oligomeric organization of *Salmonella* FliD as determined by low-resolution cryo-EM analysis ([@bib38]) ([Figure 2d](#fig2){ref-type="fig"}). Indeed, despite the difference in the stoichiometries of the *Pseudomonas* and *Salmonella* FliD oligomers, the gross measurements are nearly identical for these two proteins of similar molecular weight. In our crystal structure, *Pseudomonas* FliD measures 136 Å in diameter with a head region that is 30 Å deep and a leg region that is 55 Å long; whereas, in the cryo-EM structure, *Salmonella* FliD measures 145 Å in diameter with a head region that is 30 Å deep and a leg region that is 55 Å long ([@bib38]).10.7554/eLife.18857.007Figure 2.*Pseudomonas* FliD forms hexamers in crystals.(**a**) Top view, cartoon representation of the FliD~78--405~ hexamer. Each monomer subunit is colored distinctly and inner diameter dimension is indicated. (**b**) Side view, cartoon representation of the FliD~78--405~ hexamer. Each monomer subunit is colored distinctly. Outer dimensions are indicated. (**c**) FliD~78--405~ hexamers as arranged in the crystal are stacked head-to-head and leg-to-leg (shown) in an alternating fashion, with residues 303--308 assembling in the Head 1 domain of an opposing molecule (close-up views) leading to a dodecameric crystal packing. (**d**) Cryo-EM structure of *Salmonella* FliD from ([@bib38]) for comparison.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.007](10.7554/eLife.18857.007)

The stoichiometry of *Pseudomonas* FliD differs from that of *Salmonella* FliD and our *Pseudomonas* FliD crystals belong to the *P*6 space group, which could possibly force a non-physiological oligomeric organization of subunits. Thus, we confirmed that the hexameric assembly of FliD~78--405~ occurs not only in the crystalline environment but also in solution using negative stain EM class averaging ([@bib54]), resulting in an image that clearly exhibits a hexameric assembly ([Figure 3a](#fig3){ref-type="fig"}). These data are consistent with the oligomerization state that we detected in the crystal structure, in which a view looking down the α-helices of the leg reveals a six-membered ring organization. We also verified that both FliD~78--405~ and full-length FliD~1--474~ form oligomers by both analytical ultracentrifugation (AUC) and crosslinking analyses. We found that the FliD~78--405~ fragment that we crystallized oligomerizes up to a dodecameric state ([Figure 3b,c](#fig3){ref-type="fig"}), similar to the crystallographic assembly ([Figure 2c](#fig2){ref-type="fig"}). Additionally, we collected small-angle X-ray scattering (SAXS) data of FliD~78--405~, for which the calculated radial distribution function ([Figure 3d](#fig3){ref-type="fig"}) is characteristic of an oligomeric assembly forming a hollow sphere ([@bib51]). These data produce a molecular envelope that superimposes well with our dodecameric FliD~78--405~ X-ray crystal structure ([Figure 3d](#fig3){ref-type="fig"}). Full-length FliD~1--474~, by contrast, forms up to hexamers in solution ([Figure 3e,f](#fig3){ref-type="fig"}), which are likely to represent the physiologically relevant oligomerization state of this protein on the tip of the flagellum. The predominant tetrameric species in solution identified by AUC may be a stable intermediate on the path to hexamer formation ([Figure 3e](#fig3){ref-type="fig"}).10.7554/eLife.18857.008Figure 3.*Pseudomonas* FliD oligomerization.(**a**) Negative stain EM image of FliD~78--405~: left, single particles (scale bar=1000 Å); right, class-averaged particle (scale bar=50 Å). (**b**) AUC analysis of FliD~78--405~ proteins at pH 8.0 (upper panel) and pH 5.0 (lowel panel) indicates that it forms dodecamers in solution. (**c**) Silver-stained SDS-PAGE after chemical crosslinking of FliD~78--405~. (**d**) SAXS analysis of FliD~78--405~. Kratky plot (*I*\*q^2 ^*versus q*) and radial distribution function calculated by GNOM, and SAXS envelopes calculated by DAMMIF, with superimposed crystal structures are shown for FliD~78--405~ at 10.7 mg/mL (red, used to calculate envelope), 5.4 mg/mL (blue) and 2.7 mg/mL (grey). (**e**) AUC analysis of full length FliD~1--474~ proteins at pH 8.0 (upper panel) and pH 5.0 (lower panel) indicates a mixture of oligomers, including tetramers and hexamers. (**f**) Silver-stained SDS-PAGE after chemical crosslinking of FliD~1--474~.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.008](10.7554/eLife.18857.008)

As the hexameric assembly of full-length *Pseudomonas* FliD~1--474~ proved to be unstable in solution in the absence of the flagellar filament, we sought to stabilize it using our newfound understanding of its structure. We used our crystal structure of FliD~78--405~, as input to Disulfide by Design 2.0 ([@bib11]), to identify cysteine mutations that would lead to a stable, disulfide-bridged hexameric FliD~1--474~. We found that when two residues within neighboring head domain subunits, I167 and D253, were each mutated to a cysteine residue ([Figure 4a](#fig4){ref-type="fig"}) a stable, hexameric full-length FliD~1--474(I167C/D253C)~ resulted under non-reducing conditions, as shown by SDS-PAGE ([Figure 4b](#fig4){ref-type="fig"}) and SAXS ([Figure 4c](#fig4){ref-type="fig"}) analyses. We also confirmed that the cysteine bridges resulted in the expected interfaces between head domains by employing mass spectrometry to compare the peptide coverage under reducing and non-reducing conditions ([Figure 4---figure supplement 1a](#fig4s1){ref-type="fig"}) and by successfully detecting the correct cysteine bridges (C167--C253) while ruling out non-specific cysteine bridging (C167--C167 and C253--C253) ([Figure 4---figure supplement 1b--e](#fig4s1){ref-type="fig"}).10.7554/eLife.18857.009Figure 4.Stable hexameric DM1-FliD~1--474~ complements *P. aeruginosa* PAO1 dFliD transposon strain.(**a**) Location of residues I167 and D253, which were predicted by the web server Disulfide by Design 2.0 ([@bib11]) to form stable disulfide bridges after mutation to cysteines. (**b**) FliD~1--474(I167C/D253C)~ analyzed under reducing (lane 1) and non-reducing (lane 2) conditions by SDS-PAGE. (**c**) SAXS analysis of FliD~1--474(I167C/D253C)~. Kratky plot (*I*\*q^2 ^*versus q*) and radial distribution function calculated by GNOM for 9.75 mg/mL (blue, used to calculate envelope), 4.88 mg/mL (red) and 2.44 mg/mL (grey). SAXS envelope calculated by DAMMIF with superimposed FliD~78--405~ crystal structure. (**d**) Swimming motility assay of wildtype PAO1 (WT), FliD transposon strain PW2975 (Δ*fliD*), Δ*fliD* complemented with FliD~1--474~ (Δ*fliD/fliD~1--474~*) or FliD~1--474(I167C/D253C)~ (Δ*fliD/fliD~1--474(I167C/D253C)~*), respectively. (**e**) Western blot using anti-FliD scFv-Fc SH1579-B7 showing purified protein FliD~1--474(I167C/D253C)~ under reducing (lane 1) and under non-reducing (lane 2) conditions. The presence of FliD in flagella preparations from wildtype PAO1 (lane 4), Δ*fliD* (lane 5), Δ*fliD/fliD~1--474~*(lane 6) and Δ*fliD/fliD~1--474(I167C/D253C) ~*(lane 7) was analyzed under non-reducing conditions. The molecular weight standard is shown in lane 3 and the corresponding molecular weights are indicated on the right side of the blot. The 50 kDa and the 300 kDa bands representing FliD~1--474~ or hexameric FliD~1--474(I167C/D253C),~ respectively, are indicated by red arrows.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.009](10.7554/eLife.18857.009)10.7554/eLife.18857.010Figure 4---figure supplement 1.Analysis of FliD~1--474(I167C/D253C)~ peptides following pepsin digestion under reducing and non-reducing conditions.(**a**) Comparison of peptide coverage maps determined by LC/MS after pepsin digestion in the presence or absence of TCEP. Shown in light blue are the peptides that are identified only after treatment with TCEP, in dark blue are peptides identified both in the presence and in the absence of TCEP. The introduced cysteine residues are highlighted in red. (**b**) Peptides containing the introduced cysteines that were identified by Biopharmalynx in the presence and/or absence of TCEP are tabulated along with retention time (RT), and the number and percentage of b/y ions identified. (**c--e**) b/y fragment ions for three peptides surrounding the introduced cysteines as identified by Biopharmalynx in the presence and absence of TCEP. (**c**) and (**e**) show the b/y ions for peptides 165--176 and 251--257. (**d**) shows the b/y ions identified for the disulfide-bridged peptide 165--176 x 251--257.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.010](10.7554/eLife.18857.010)10.7554/eLife.18857.011Figure 4---figure supplement 2.Western blot analysis of PAO1 strain flagella preparations.Coomassie-stained membrane of the Western blot displayed in [Figure 4e](#fig4){ref-type="fig"} showing purified protein FliD~1--474(I167C/D253C)~ under reducing (lane 1) and under non-reducing (lane 2) conditions. The presence of FliC in flagella preparations from wildtype PAO1 (lane 4), Δ*fliD* (lane5), Δ*fliD/fliD~1--474~*(lane 6) and Δ*fliD/fliD~1--474(I167C/D253C)~*(lane 7) was analyzed under non-reducing conditions. The molecular weight standard is shown in lane 3 and the molecular weights are listed on the right side of the membrane. The 50 kDa FliC bands are indicated by black arrows.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.011](10.7554/eLife.18857.011)10.7554/eLife.18857.012Figure 4---figure supplement 3.Swimming motility assay.Swimming motility of wildtype PAO1 (WT), FliD transposon strain Δ*fliD*, Δ*fliD* complemented with FliD~1--474~ with an optimized codon usage for *Echerichia coli* expression (Δ*fliD/fliD~PAOfliDe~*) or *Salmonella typhimurium* FliD~1--467~ with an optimized codon usage for *E. coli* expression (Δ*fliD/fliD~StyFliDe~*).**DOI:** [http://dx.doi.org/10.7554/eLife.18857.012](10.7554/eLife.18857.012)

To show that the hexameric form of *Pseudomonas* FliD is functional in vivo, we complemented the *fliD* transposon strain PW2975 (Δ*fliD*) with wildtype *fliD~1--474~* and hexamer-stabilized *fliD~1--474(I167C/D253C)~*, resulting in *Pseudomonas* PAO1 strains Δ*fliD/fliD~1--474~* and Δ*fliD/fliD~1--474(I167C/D253C)~*, respectively. We found that swimming motility that was lost in the Δ*fliD* strain was restored in both Δ*fliD/fliD~1--474~* and Δ*fliD/fliD~1--474(I167C/D253C)~* complementation strains, similar to our observations in the wildtype *Pseudomonas* PAO1 strain ([Figure 4d](#fig4){ref-type="fig"}). Using antibodies that we generated by phage display to *Pseudomonas* PAO1 FliD, we confirmed the expression of full-length FliD proteins by Western blot analysis from preparations of flagella isolated from live bacteria from both Δ*fliD/fliD~1--474~* and Δ*fliD/fliD~1--474(I167C/D253C)~* complementation strains ([Figure 4e](#fig4){ref-type="fig"}). In flagella preparations from the Δ*fliD/fliD~1--474(I167C/D253C)~* complementation strain, the FliD~1--474(I167C/D253C)~ protein produced by *Pseudomonas* maintains its hexameric oligomeric state ([Figure 4e](#fig4){ref-type="fig"}). In contrast, subsequent to flagella isolation from live bacteria, FliD~1--474~ does not maintain a stable hexameric complex in either the wildtype *Pseudomonas* PAO1 strain or in the Δ*fliD/fliD~1--474~* complementation strain ([Figure 4e](#fig4){ref-type="fig"}). The Δ*fliD* transposon strain does not form flagella, as indicated by the lack of FliC in the analyzed flagella preparations (lane 5 on the stained Western blot membrane, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). In comparison, the wildtype and all complementation strains form flagella as indicated by the presence of flagellin/FliC in the purified flagella samples ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Together, these data indicate that FliD that is covalently locked in its hexameric assembly can form functional flagella that allow *Pseudomonas* bacteria to swim like *Pseudomonas* with wildtype FliD. Thus, the hexamer oligomeric state of *Pseudomonas* FliD is functional in vivo.

We also tested whether *Salmonella* FliD, which is known to form pentamers when capping the flagellar filament, could function as a capping protein for *Pseudomonas* flagella. In contrast to the in vivo functional hexameric forms of *P. aeruginosa* FliD~--474~, complementation of the PAO1 PW2975 transposon strain with *fliD* from *Salmonella typhimurium* (Δ*fliD/fliD~StyFliDe~*) did not restore swimming motility ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). As this clone was codon-optimized for expression in *Escherichia coli*, we also confirmed that a wildtype PAO1 full-length FliD~1--474~ encoded by a similarly codon-optimized gene did restore swimming motility in the ΔfliD strain (Δ*fliD/fliD~PAOfliDe~*; [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Although there exist many possible reasons other than oligomeric state that could explain the inability of *Salmonella* FliD to functionally complement *Pseudomonas*, these data suggest that *Pseudomonas* flagella may prefer FliD proteins that adopt hexameric rather than pentameric states.

Regions outside of the head domains drive FliD oligomerization {#s2-4}
--------------------------------------------------------------

Although the FliD~78--405~ crystal structure exhibits intermolecular contacts between the head regions of FliD~78--405~ subunits comprising the hexamer, each of these interfaces is small, with a buried surface area of only 665 Å^2^, and contains few intermolecular contacts ([Figure 5a](#fig5){ref-type="fig"}) relative to typical protein--protein interactions ([@bib25]). To determine whether these interactions were sufficient to drive oligomerization of FliD, we expressed and purified the head region only, FliD~78--273~. By AUC ([Figure 5b](#fig5){ref-type="fig"}), chemical crosslinking ([Figure 5c](#fig5){ref-type="fig"}) and SAXS analysis ([Figure 5d](#fig5){ref-type="fig"}), we observed that when FliD lacks the leg region and the N- and C-terminal coiled-coil domains, it is present predominantly in the form of monomers (and dimers to a lesser extent) in solution, but fails to form higher-order oligomers as do the longer versions of FliD that we analyzed. Because different buffer conditions, including changes in pH, have been shown to affect the polymerization states of flagellar filaments ([@bib48]) and capping proteins ([@bib24]), we performed additional AUC experiments and found that FliD~78--273~ is entirely monomeric at pH 8.0 and becomes approximately one-third dimeric at pH 5.0; we observed no higher-order oligomers of FliD~78--273~ regardless of buffer conditions ([Figure 5b](#fig5){ref-type="fig"}). We also assessed, by chemical cross-linking, the oligomerization states of FliD variants lacking only the N-terminal coiled-coil domain (FliD~78--474~; [Figure 5e](#fig5){ref-type="fig"}) or the C-terminal coiled-coil domain (FliD~1--405~; [Figure 5f](#fig5){ref-type="fig"}). We found them to be mainly monomeric with a minority of species appearing to dimerize, although the latter exhibit weak higher-order oligomerization potential. Kratky plots and radial distribution functions calculated from SAXS data of the variants lacking either the N- or C-terminal coiled-coil domain, FliD~78--474~ or FliD~1--405~ respectively, reveal that these proteins adopt extended shapes with flexible regions that are clearly represented in the resulting molecular envelopes ([Figure 6a,b](#fig6){ref-type="fig"}). These data indicate that the driving force for hexamerization of *Pseudomonas* FliD resides in molecular determinants outside of the head region and, at a minimum, involves residues in the N-terminal and C-terminal coiled-coil domains. FliD~78--405~ is lacking the C-terminal and N-terminal coiled-coil domain but still assembles into dodecamers, as shown in the crystal structure, cross-linking experiments and AUC, which is likely caused by strand replacement in the head region domain 1 and helix--helix (residues 274--308) interaction of stacked molecules ([Figure 2c](#fig2){ref-type="fig"}).10.7554/eLife.18857.013Figure 5.Molecular determinants of *Pseudomonas* FliD oligomerization reside outside of the stable head region.(**a**) Intermolecular interface formed between head region monomer subunits, with an \'open book\' rendering of the interface expanded below. Head domain 1 is yellow; domain 2 is orange; interface oxygen and nitrogen atoms are red and blue, respectively. (**b**) AUC analysis of the head region alone, FliD~78--273~, at pH 8.0 (upper panel) and pH 5.0 (lower panel) reveals a monomeric species at pH 8.0 and the additional minor presence of a dimeric species at pH 5.0. (**c**) Silver-stained SDS-PAGE after chemical crosslinking of FliD~78--273~. (**d**) SAXS analysis of FliD~78--273~. Kratky plot (*I*\*q^2 ^*versus q*) and radial distribution function calculated by GNOM and SAXS envelopes calculated by DAMMIF with superimposed crystal structures are shown for FliD~7--273~ at 1.34 mg/mL (blue), 0.67 mg/mL (red, used to calculate the envelope) and 0.335 mg/mL (green). (**e**) Silver-stained SDS-PAGE after chemical crosslinking of FliD~78--474~. (**f**) Silver-stained SDS-PAGE after chemical crosslinking of FliD~1--405~.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.013](10.7554/eLife.18857.013)10.7554/eLife.18857.014Figure 6.Small angle X-ray scattering (SAXS) data of FliD~1--405~, FliD~78--474~ and FliD~1--474~.Log-scale intensity SAXS profiles, Kratky Plot (*I* × *q*^2 ^*versus q*), radial distribution function calculated by GNOM and SAXS envelopes calculated by DAMMIF are shown for: (**a**) FliD~1--405~ at 10.4 mg/mL (blue), 5.2 mg/mL (red) and 2.6 mg/mL (grey); (**b**) FliD~78--474~ at 9.9 mg/mL (blue), 4.95 mg/mL (red) and 2.5 mg/mL (grey); and (**c**) FliD~1--474~ at 11 mg/mL (blue), 5.5 mg/mL (red), 2.7 mg/mL (grey), 1.38 mg/mL (green) and 0.69 mg/mL (yellow).**DOI:** [http://dx.doi.org/10.7554/eLife.18857.014](10.7554/eLife.18857.014)10.7554/eLife.18857.015Figure 6---figure supplement 1.Analytical ultracentrifugation (AUC) analysis of FliD~1--474~ at pH 11.0.AUC analysis of FliD~1--474~ at pH 11.0 indicates that the protein is monomeric at pH 11.0.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.015](10.7554/eLife.18857.015)

The N- and C-terminal regions of FliD are highly flexible {#s2-5}
---------------------------------------------------------

A large extent of FliD sequence currently remains inaccessible to high-resolution structural analysis, including *Pseudomonas* FliD residues 1--79 and 309--474. Consequently, we performed hydrogen/deuterium (H/D) exchange-mass spectrometry (HDX-MS) experiments with FliD~78--405~ to define its solvent accessible regions and to evaluate its dynamic behavior. We subjected FliD~78--405~ to H/D exchange for 10 s to 2 hr and observed that the head region (residues 80--273) of FliD~78--405~ adopts a largely stable exchange-protected fold with greater stability observed for domain 2 relative to that of domain 1. The leg region, particularly residues C-terminal to the α helix observed in the crystal structure, is more disordered or less stable ([Figure 7a](#fig7){ref-type="fig"}). Residues linking head domain 1 to the leg helix display cooperative unfolding behavior as indicated by EX1 kinetics ([@bib60]) that result in double isotopic envelopes ([Figure 7b](#fig7){ref-type="fig"}). The FliD~78--405~ protein used in these experiments was folded properly as shown by circular dichroism, as were all other FliD protein fragments that we produced ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). When mapped to our crystal structure of FliD~78--405~, the degree of H/D exchange over time on the peptide level corresponds to the degree of conformational stability on the residue level ([Figure 7c](#fig7){ref-type="fig"}). When we used a difference plot to compare the extent of H/D exchange of full length FliD~1--474~ with that of FliD~78--405~, we observed that residues 165--225 exhibit relatively greater stability in FliD~78--405~ ([Figure 8a](#fig8){ref-type="fig"}). Within this stretch of residues in head domain 2 are those residues, 165--171, which form the interface between the two head region domains in the hexameric complex ([Figure 8b](#fig8){ref-type="fig"}). We observed an additional region of relative stabilization for residues 298--324, part of which, residues 300--308, correspond to the β strand replacement in the opposing head region domain 1 that drives dodecamer formation of FliD~78--405~ ([Figure 8a](#fig8){ref-type="fig"}). Kratky plots calculated from SAXS data of full-length FliD~1--474~ at pH 11, which is monomeric under these conditions ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), confirms the overall flexible nature of this protein. Accordingly, heterogeneous molecular envelopes calculated from SAXS data collected at different concentrations of FliD~1--474~ also exhibit significant conformational flexibility ([Figure 6c](#fig6){ref-type="fig"}).10.7554/eLife.18857.016Figure 7.Regions of *Pseudomonas* FliD outside of the head domains and initial leg helix are highly dynamic.(**a**) Hydrogen/deuterium exchange analysis of FliD~78--405~. Percent deuteration (%D) heat map is shown. Peptides exhibiting EX1 kinetics are indicated. (**b**) Mass spectra of four FliD peptides exhibit double isotopic envelopes characteristic of EX1 kinetics (*below*). Three of these peptides are mapped to the crystal structure (*above*; FliD hexamers are in green and gold). (**c**) Conformational stability as determined by hydrogen/deuterium exchange mapped to the crystal structure of FliD~78--405~ using the same color coding for %D as shown in (**a**).**DOI:** [http://dx.doi.org/10.7554/eLife.18857.016](10.7554/eLife.18857.016)10.7554/eLife.18857.017Figure 7---figure supplement 1.Circular dichroism analysis of FliD variants.(**a**) CD spectra recorded from 190 to 260 nm and (**b**) melting curves recorded from 15 to 90°C are shown for FliD~78--405~, FliD~1--474~, FliD~78--273~, FliD~78--474~ and FliD~1--405~. Melting curves were recorded at 222 nm for all proteins except for FliD~78--273~, which was analyzed at 205 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.017](10.7554/eLife.18857.017)10.7554/eLife.18857.018Figure 8.Interaction of *Pseudomonas* FliD regions.(**a**) Difference plot of hydrogen/deuterium exchange data from full length FliD~1--474~ and the crystallized fragment, FliD~78--405~. (**b**) Hydrogen/deuterium exchange for peptides corresponding to residues 166--176 (*top*, marked by + in (**a**) and (**b**)) and residues 225--239 (*bottom*, marked by \* in (**a**) and (**b**)). Positions of peptides 166--176 and 225--239 in the FliD~78--405~ crystal structure (*right*). (**c**) Difference plots of hydrogen/deuterium exchange data from full length FliD~1--474~ and the fragments missing only the C-terminal coiled coil, FliD~1--405~, only the N-terminal coiled coil, FliD~78--474~, or both the N- and C-terminal coiled coils and the leg domain, FliD~78--273~ (*top, middle and bottom, respectively*). (**d**) Schematic model of the FliD monomeric subunit showing the N-terminal coiled coil stabilizing the head 1 and foot domains and also interacting with the C-terminal coiled coil.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.018](10.7554/eLife.18857.018)10.7554/eLife.18857.019Figure 8---figure supplement 1.Hydrogen-deuterium exchange-mass spectrometry analysis of FliD variants.Heat maps of hydrogen/deuterium exchange for FliD~1--474~, FliD~78--405~, FliD~78--474~, FliD~1--405~ and FliD~78--273~, from top to bottom, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.019](10.7554/eLife.18857.019)10.7554/eLife.18857.020Figure 8---figure supplement 2.Analytical ultracentrifugation (AUC) analysis of FliD~1--474~ at 4 μM.AUC analysis of FliD~1--474~ at a concentration of 4 μM at pH 8.0 indicates that the protein is predominantly monomeric in an equilibrium with dimeric species at 4 μM and pH 8.0.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.020](10.7554/eLife.18857.020)10.7554/eLife.18857.021Figure 8---figure supplement 3.FliD intrinsic disorder analysis.Intrinsic disorder prediction of FliD~1--474~ using publicly available algorithms (*as indicated, left column*). Averaging of the results (*color, bottom row*) was done giving all servers equal weight.**DOI:** [http://dx.doi.org/10.7554/eLife.18857.021](10.7554/eLife.18857.021)

Multiple regions of FliD interact with one another {#s2-6}
--------------------------------------------------

To gain further insight to the dynamics and interactions of the different regions of FliD, we performed HDX-MS experiments with the remaining *Pseudomonas* FliD fragments that we had generated ([Figure 1a](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). HDX-MS heat maps show the overall high degree of flexibility of FliD regions outside the head domain ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), and difference plots of FliD truncations in comparison to the full length FliD~1--474~ indicate that the head region, and more specifically head region domain 1, is stabilized by FliD regions outside of the head region ([Figure 8c](#fig8){ref-type="fig"}). Indeed, the N-terminal coiled coil is responsible for this stabilization of head region domain 1, in addition to stabilization of residues between the leg region α helix and the C-terminal coiled coil ([Figure 8c](#fig8){ref-type="fig"}). Finally, the C-terminal coiled coil predominantly stabilizes residues in the N-terminal coiled coil ([Figure 8c](#fig8){ref-type="fig"}). The stabilization of one FliD region by another is most likely to be direct and intramolecular, rather than allosteric and intermolecular, as the full-length protein FliD~1--474~ adopts predominantly monomeric species under the conditions that we used for HDX-MS analysis ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). This leads to a transient structural model of the entire FliD monomer subunit ([Figure 8d](#fig8){ref-type="fig"}) in which the N-terminal coiled coil bridges the head and foot regions and is itself pinned to these structural elements by the C-terminal coiled coil. Notably, none of the flexible regions of FliD, save the C-terminal 20 residues, are consistently predicted by sequence analysis to be intrinsically disordered ([Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}); rather, they are inherently capable of adopting a limited number of conformations required to be in an \'on-state\' (actively chaperoning and sorting a FliC protein) or an \'off-state\' (engaging only structured and previously positioned FliC proteins).

Discussion {#s3}
==========

At the gross structural level, our studies show that the oligomeric states differ between FliD protein assemblies in diverse bacteria. *Salmonella* has long served as the model for bacterial flagellum structure and function. Since *Salmonella* FliD performs its native flagellar capping function as a pentamer ([@bib24]; [@bib37]; [@bib58]; [@bib63]), it could reasonably be assumed that all FliD proteins form pentamers at the distal ends of all bacterial flagella. We found that *Pseudomonas* FliD instead forms hexamers both in crystals and in solution. Additionally, we showed that *Pseudomonas* FliD constrained to its hexameric state by inter-subunit disulfide bonds is functional in vivo, resulting in the formation of flagella and swimming motility. Conversely, *Salmonella* FliD that assembles as pentamers does not allow flagellar formation and swimming motility in *Pseudomonas* bacteria.

Much like cryo-EM studies of flagellar filaments from diverse bacteria unequivocally showed that the number of protofilaments ranges, at least, from 11 in *Salmonella* ([@bib64]) to seven in *Campylobacter* ([@bib18]), our structural analyses show that the proteins that cap these filaments also vary in their oligomeric states. The end of the *Salmonella* filament exhibits a non-planar surface with five indentations ([@bib63]) into which the five legs of the corresponding FliD pentamer have been modeled ([@bib38]). Although no structure of the *Pseudomonas* filament has been determined even at low resolution, our hexameric FliD structure suggests that it may incorporate an even greater number of protofilaments than does the *Salmonella* filament. This would allow the formation of an additional molecular cavity on the distal end of FliD that accommodates its unique capping protein hexamer. Indeed, *Pseudomonas* flagellar filaments have been found to be macroscopically different from those of *Salmonella* ([@bib48]).

At 2.2 Å resolution, our crystal structure reveals several previously unknown structural features of FliD that are likely to be critical to its function. First, each one of the six FliD head regions that appear as discreet lobes when visualized by EM analysis is actually composed of the first and second domains of neighboring monomer subunits, as opposed to both domains belonging to the same subunit. This is likely the case for FliD oligomers from diverse bacteria, including *Salmonella* FliD for which cryo-EM analyses showed five head region lobes ([@bib38]; [@bib63], [@bib64]). Second, despite vanishingly low sequence similarity, each domain within the head region exhibits high structural similarity to the corresponding domains of other flagellar proteins, including the hook-filament junction protein/FlgK and flagellin/FliC. Thus, at least one protein domain from the proteins that occupy the distal ends of the hook (FlgK) and the cap (FliD) adopts a common structural fold, which may be required for and unique to their function at these related positions within the flagellum. This domain conservation among flagellar proteins confirms a previous study proposing a structural relationship of FliD to other flagellar proteins despite their low sequence similarities ([@bib58]). This structural conservation suggests that a structurally similar cap complex may form at both hook and on the distal end. It also suggests that FliD may play a functional role earlier in the flagellar assembly process, prior to its known FliC sorting function. Notably, in mutants of *Salmonella* that lack filaments, FlgK (HAP1), FliD (HAP2) and FlgL (HAP3) form a layered structure at the distal end of the hook-basal body ([@bib22]). In addition, the shared domain structure of portions of FliC and FliD suggests that the chaperoning activity of FliD could derive, at least in part, from its presentation of a like-structured template against which FliC subunits may fold prior to being positioned into the growing filament.

Owing to the conformational flexibility of FliD necessitated by its FliC sorting function, we still lack high-resolution structural information for certain regions of this protein. However, using a number of biophysical methods, we found that molecular determinants outside of the conformationally stable head regions control FliD oligomerization. Previous analysis of a trypsinized fragment of *Salmonella* FliD that lacks the N-terminal 42 residues and C-terminal 51 residues, which is similar to the *Pseudomonas* FliD~78--405~ protein that we crystallized, showed that this fragment can form pentamers but not decamers in solution and dissociates into smaller oligomers at low temperatures ([@bib58]). This suggests that determinants outside of the head regions of FliD proteins of diverse bacteria control their oligomeric states. Accordingly, we showed that FliD, when constrained to its hexameric state by disulfide bonds formed between neighboring head domain subunits, is fully functional in vivo. Thus,conformational flexibility in or relative repositioning of the head regions are not functional requirements of FliD but flexibility in regions outside of the head regions undoubtedly is. Considering that inhibiting protein--protein interfaces with small molecules remains a major technical challenge ([@bib3]), the dependence of FliD oligomeric assembly on its flexible regions enhances the prospects of developing small molecule inhibitors of FliD oligomerization, and consequently of flagellar function, as a novel class of antibiotic agents.

Materials and methods {#s4}
=====================

Plasmids {#s4-1}
--------

For crystallization, the coding sequence optimized for expression in *E. coli* of FliD~78--405~ from the PAO1 strain of *P. aeruginosa* was synthesized and cloned into the pET-28b vector (Novagen) with the inclusion of an N-terminal His~6~-tag followed by a tobacco etch virus (TEV) protease recognition site. A FliD~78--405~ mutant encoding four leucine to methionine mutations at positions L135, L239, L347 and L350 (FliD~78--405~/L~4~-M~4~) was synthesized and likewise cloned into the pET-28b vector with an N-terminal His~6~-tag. For all other experiments, FliD~78--405~, full-length FliD (FliD~1﻿--474~), head domain-only FliD (FliD~78﻿--273~), and FliD lacking the N-terminal (FliD~78﻿--474~) or C-terminal (FliD~1﻿--405~) coiled-coil domains were codon-optimized for expression in *E. coli* and cloned into pGEX5x2 in frame with an N-terminal GST-tag followed by a TEV protease site. To obtain a stable hexameric full-length FliD mutant (FliD~1﻿--474(I167C/D253C)~), two residues (I167 and D253) located at the interface between neighboring head domains were mutated to cysteine residues in wildtype FliD~1--474~.

Recombinant protein expression and purification {#s4-2}
-----------------------------------------------

All FliD constructs from the *P. aeruginosa* PAO1 strain were expressed in LB medium for 4 hr at 37°C in *E. coli* BL21(DE3)pLysS cells after induction with 1 mM IPTG at an OD~600nm~ of 0.6. Seleno-methionine (SeMet)-labeled FliD~78﻿--405~/L~4~-M~4~ was produced using metabolic inhibition of methionine biosynthesis ([@bib57]) and growth in M9 medium containing 60 mg/L SeMet as the sole source of methionine for 6 hr after induction with 1 mM IPTG. Cells were harvested (5000 g for 15 min) and lysed in PBS including 5 mM β-mercaptoethanol by sonication. For crystallization of His-tagged FliD~78﻿--405~ and His-tagged FliD~78﻿--405~/L~4~-M~4,~the soluble fraction was purified using HisPur NiNTA Resin (Thermo Scientific). The protein was further purified by size exclusion chromatography (Superdex 200 10/300 GL, GE Healthcare) in PBS followed by anion exchange chromatography (MonoQ 5/50 GL, GE Healthcare). For crystallization the protein was dialyzed into 30 mM Tris pH 8.0, 80 mM sodium chloride and concentrated to approximately 13 mg/mL. FliD-GST-fusion constructs were purified using a Glutathione Sepharose (BioVision) column. Following 16 hr digestion with TEV protease, the GST tag was removed by Glutathione Sepharose and TEV was removed by NiNTA (Thermo Scientific) chromatography. Cleaved FliD constructs were further purified using size exclusion (Superdex 200 10/300 GL, GE Healthcare) in PBS followed by anion exchange chromatography (MonoQ 5/50 GL, GE Healthcare) using 20 mM CHES pH 9.0 and a linear salt gradient from 0 to 1 M NaCl over 12 min.

Protein crystallization {#s4-3}
-----------------------

Crystals of FliD~78﻿--405~ obtained in 0.25 M L-Arginine, 0.1 M Tris/HCl pH 8.0, 8% PGA diffracted poorly and were subsequently used for random microseeding matrix screening (rMMS) ([@bib12]). Improved crystals of FliD~78﻿--405~ were grown in 0.8 M NaK Tartrate, 0.1 M Hepes pH 7.5 and diffracted to 2.2 Å. Crystals of SeMet-labeled FliD~78﻿--405~/L~4~-M~4~ were also obtained by employing rMMS with the initial, poorly diffracting crystals of FliD~78﻿--405~, which resulted in FliD~78﻿--405~/L~4~-M~4~ crystals grown in 1.5 M ammonium sulfate, 0.1 M Tris pH 8.5, 10% glycerol diffracting to 3.6 Å (anomalous signal cuttoff). Crystals were harvested and flash cooled in liquid nitrogen in mother liquor supplemented with 25% to 30% glycerol as cryo-protectant.

X-ray diffraction data processing, structure determination and refinement {#s4-4}
-------------------------------------------------------------------------

X-ray diffraction data for the SeMet-labeled FliD~78﻿--405~/L~4~-M~4~ crystal were collected using a Dectris 6M PILATUS detector on the 12--2 beamline at the Stanford Synchrotron Radiation Lightsource, SSRL, processed using XDS ([@bib28]), scaled in AIMLESS ([@bib16]; [@bib61]), and phases obtained using the SSRL multi-wavelength anomalous dispersion (MAD) script by A. Gonzalez with SHELX options based on a script by Qingping Xu, including the programs SHELX ([@bib46]), SOLVE ([@bib55]) and RESOLV ([@bib56]). The initial FliD~78﻿--405~/L~4~-M~4~ model was improved manually by rebuilding the peptide chain backbone in Coot ([@bib15]) and refining using Phenix ([@bib1]). Diffraction data for native, wildtype FliD~78﻿--405~ were collected using a MARmosaic 300 CCD detector on the 23ID-B beamline at the Advanced Photon Source, Argonne National Laboratory, APS, and processed using XDS ([@bib28]) and XSCALE ([@bib27]). The partially built and refined SeMet-FliD~78﻿--405~/L~4~-M~4~ model was used as a molecular replacement model for phasing the native FliD~78--405~ data using Phaser ([@bib40]). The initial native FliD~78--405~ model was build using Autobuild and improved by manual model rebuilding in Coot ([@bib15]) and by iterative rounds of refinement using Phenix ([@bib1]).

Mass spectrometry {#s4-5}
-----------------

FliD~78--405~ crystals were crosslinked using 2% formaldehyde, harvested and washed in mother liquor, dissolved in water and the crosslinking reversed by heating the samples to 95°C for 20 min. The samples were analyzed by liquid chromatography (LC)-electrospray ionization (ESI)-mass spectrometry (MS) using a gradient of mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% formic acid in acetonitrile) increasing from 0% B to 90% B in 20 min. The Accela LC System was attached to a LXQ linear ion trap mass spectrometer (Thermo Scientific). Raw MS data were analyzed using Xcalibus Qual Browser (Thermo Scientific) and deconvoluted using BioWorks (Thermo Scientific, Waltham, MA).

Circular dichroism {#s4-6}
------------------

10 μM FliD protein in 10 mM sodium phosphate pH 7.0 was used to record a spectrum ranging from 190 nm to 260 nm at 15°C. CD melting curves were analyzed at 222 nm or 205 nm by increasing the temperature by 1°C per minute starting at 15°C using a JASCO J810 CD instrument according to the manufacturer's instructions.

Electron microscopy {#s4-7}
-------------------

An aliquot of a FliD~78--405~ protein sample was negatively stained with 2% (weight/volume) uranyl acetate and imaged using a Tecnai F20 (FEI) electron microscope operating at 120 keV. Approximately 3500 particles were selected from 70 micrographs and used to generate class averages in EMAN2 ([@bib54]). Six classes were generated, and [Figure 3a](#fig3){ref-type="fig"} shows the single largest class.

Small angle X-ray scattering (SAXS) {#s4-8}
-----------------------------------

Small angel x-ray scattering data were collected using a dual Pilatus 100K-S SAXS/WAXS detector at beamline G-1 of the Macromolecular Diffraction Facility at the Cornell High Energy Synchrotron Source (MacCHESS). Scattering was measured in 30 mM Tris pH 8.0, 80 mM NaCl of FliD~78--405~ at 10.7 mg/mL, 5.4 mg/mL and 2.7 mg/mL, of FliD~78--273~ at 1.34 mg/mL, 0.67 mg/mL and 0.335 mg/mL, of FliD~1--405~ at 10.4 mg/mL, 5.2 mg/mL and 2.6 mg/mL, of FliD~78--474~ at 9.9 mg/mL, 4.95 mg/mL and 2.6 mg/mL and of FliD~1--474(I167C/D253C)~ at 9.75 mg/ml, 4.88 mg/ml and 2.44 mg/ml. Scattering of monomeric full-length FliD~1--474~ at 11 mg/mL, 5.5 mg/mL, 2.75 mg/mL, 1.38 mg/mL and 0.69 mg/mL was measured in 20 mM CAPS pH 11.0, 80 mM NaCl. The SAXS data were processed using the BioXTAS RAW software ([@bib42]) and radial distribution functions calculated using GNOM ([@bib53]). Molecular envelopes were generated using GASBOR ([@bib52]) and DAMMIF ([@bib34]). FoXS ([@bib47]) was used to verify the calculated intensity plots of the structures of the head domain FliD~78--273~ and the dodecameric FliD~78--405~. The X-ray crystal structures of FliD~78--273~ and FliD~78--405~ were superimposed onto the envelopes.

Hydrogen/deuterium exchange-mass spectrometry {#s4-9}
---------------------------------------------

The coverage maps for FliD~1--474~ and FliD~78--405~ were obtained from undeuterated controls as follows: 3.5 µL of \~40 µM FliD in 30 mM TrisHCl, 150 mM NaCl pH 8.0 was diluted with 31.5 µL of the same buffer at room temperature followed by the addition of 100 µL of ice cold quench (100 mM Phosphate buffer, 1.5 M Guanidine-HCl, pH 2.4). The quenched samples were injected into a Waters HDX nanoAcquity UPLC (Waters, Milford, MA) with in-line pepsin digestion (Waters Enzymate BEH pepsin column). Peptic fragments were trapped on an Acquity UPLC BEH C18 peptide trap and separated on an Acquity UPLC BEH C18 column. A 7 min, 5% to 35% acetonitrile (0.1% formic acid) gradient was used to elute peptides directly into a Waters Synapt G2 mass spectrometer (Waters, Milford, MA). MS^E^ data were acquired with a 20 to 30 V ramp trap CE for high energy acquisition of product ions as well as continuous lock mass (Leu-Enk) for mass accuracy correction. Peptides were identified using the ProteinLynx Global Server 2.5.1 (PLGS) from Waters. Further filtering of 0.3 fragments per residues was applied in DynamX.

For each construct, the HD exchange reactions were performed as follows: 3.5 µL of \~40 µM FliD in 30 mM TrisHCl, 150 mM NaCl pH 8.0 was incubated in 31.5 µL of 30 mM TrisDCl, 99.99% D~2~O, pD 8.0, 150 mM NaCl. All reactions were performed at 25°C. Prior to injection, deuteration reactions were quenched at various times (10 s, 1 min, 10 min, 1 hr and 2 hr) with 100 µL of 100 mM Phosphate buffer, 1.5 Guanidine-HCl, pH 2.4. Back exchange correction was performed against fully deuterated controls acquired by incubating 3.5 µL of 40 µM FliD~1--474~ in 31.5 µL 30 mM TrisDCl, 99.99% D~2~O, pD 8.0, 150 mM NaCl containing 6 M deuterated Guanidine DCl for 2 hr at 25°C prior to quenching (without guanidine HCl). All deuteration time points and controls were acquired in triplicates.

The deuterium uptake by the identified peptides through increasing deuteration time and for the fully deuterated control was determined using Water's DynamX 2.0 software. The normalized percentage of deuterium uptake (%D) at an incubation time $t$ for a given peptide was calculated as follows:$$\% D = \frac{100 \cdot (m_{t} - m_{0})}{m_{f} - m_{0}}$$

With $m_{t}$ the centroid mass at incubation time $t,m_{0}$ the centroid mass of the undeuterated control, and *m~f~* the centroid mass of the fully deuterated control. Heat maps and percent deuteration difference plots ($\Delta\% D$) were generated using the percent deuteration calculated. Confidence intervals for the $\Delta\% D$ plots were determined using the method outlined by [@bib23]), adjusted to percent deuteration using the fully deuterated controls. Confidence intervals (98%) were plotted on the $\Delta\% D$ plots as horizontal dashed lines. EX1 type cooperative unfolding was analyzed using HX-Express2 ([@bib19]).

Determination of peptide coverage of FliD~1--474(I167C/D253C)~ under reducing and non-reducing conditions {#s4-10}
---------------------------------------------------------------------------------------------------------

Coverage maps of FliD~1--474(I167C/D253C)~ in the presence and absence of reducing agent were obtained similarly as above except for the following: 3 μL of 66 μM FliD~1--474(I167C/D253C)~ were incubated for 2 hr with 15 μL of 8 M Guanidine-HCl and 2 μL of 1 M TCEP (reducing conditions) or 2 μL H~2~O (non-reducing conditions). Subsequently, 180 μL of quench buffer (100 mM potassium buffer, pH 2.4) was added and the mixture immediately injected into the Waters HDX nanoAcquity UPLC. The remainder of the workflow, MS method, peptide identification and coverage map determination was unchanged. In addition, Biopharmalynx 1.3.5 (Waters) was used to search for and to identify disulfide-bridged peptides. A filter of 15% b/y ions identified was applied. The search was performed both in the context of the expected C167--C253 disulfide bridge and forthe C167--C167 and C253--C253 disulfide bridges as negative controls.

Analytical ultracentrifugation {#s4-11}
------------------------------

The oligomeric states of FliD~78--405~, FliD~78--273~ and FliD~1--474~ in buffers containing 30 mM Tris, 80 mM NaCl, pH 8.0 or 20 mM sodium citrate, 80 mM NaCl, pH 5.0 respectively, were analyzed by sedimentation velocity using a Beckman-Coulter XL-I analytical ultracentrifuge equipped with a 4- or 8-hole An-60Ti Rotor at 20°C. SedenTerp (<http://sednterp.unh.edu>) was used to calculate protein partial specific volumes and solvent densities and viscosities from the protein amino acid sequences and buffer compositions. For sedimentation velocity measurements, samples of 295 μM (pH 8.0) or 325 μM (pH 5.0) FliD~78--405~, 124 μM FliD~78--273~, and 168 μM FliD~1--474~ were prepared in each buffer. FliD~1--474~ was also analyzed by AUC at a low concentration of 4 μM in 30 mM Tris, 80 mM NaCl, pH 8.0 and at a concentration of 43 μM at high pH in 20 mM CAPS, 80 mM NaCl, pH 11.0. After exhaustive dialysis to ensure chemical equilibrium, the samples were loaded into cells equipped with 2-hole charcoal-filled epon centerpieces (either 1.2 or 0.3 mm path length) with sapphire windows. Prior to centrifugation, samples were equilibrated in the rotor for at least 2 hr at the desired experimental temperature. Centrifugation was performed at 50,000 (FliD~78--273~), 40,000 (FliD~1--474~) or 30,000 (FliD~78--273~) rpm and scans were acquired at 280 nm. The resulting data were analyzed using DCDT+ version 2.2.1 ([@bib43]; [@bib50], [@bib49]) to determine the number of species, their sedimentation coefficients, and their fractional contributions to the species populations. All sedimentation coefficients were corrected to s~20,w~ values.

Chemical crosslinking {#s4-12}
---------------------

Approximately 0.4 mg/mL of protein in 20 mM Hepes pH 8.0, 10 mM sodium chloride was crosslinked using 20 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) and 20 mM N-hydroxysuccinimide (NHS) in 20 mM sodium phosphate, pH 7.0, 150 mM NaCl for various time points. The reaction was stopped by the addition of 0.5 M Tris-HCl pH 8.0 to a final concentration of 0.25 M. The products were analyzed on NuPAGE 3--8% Tris-Acetate gels (Life Technologies, Carlsabd, CA) or an Any kD Mini-PROTEAN TGX gels (BioRad) using a silver-staining kit (Thermo Scientific).

Complementation of *Pseudomonas aeruginosa* PAO1 {#s4-13}
------------------------------------------------

Wildtype *fliD~1474~* and *fliD~1474(I167C/D253C)~* were cloned into pUCP20 and transformed by electroporation ([@bib9]) into the Δ*fliD* transposon strain PW2975 (obtained from the Manoil Lab at the University of Washington), resulting in the strains Δ*fliD/fliD~1--474~* and Δ*fliD/fliD~1--474(I167C/D253C)~*, respectively. Wildtype *fliD~1--474~ (fliD~1--474e~*) and full-length *fliD* from *Salmonella typhimurium (fliD~StyFliDe~*) both with genes codon-optimized for *E. coli* expression were also transformed into PW2975 resulting in Δ*fliD/fliD~1--474e~* and Δ*fliD/fliD~StyFliDe~*, respectively.

Swimming motility assays {#s4-14}
------------------------

Swimming motility assays of *Pseudomonas aeruginosa* strains were performed as described by [@bib20].

Isolation of flagella and FliD detection {#s4-15}
----------------------------------------

*Pseudomonas aeruginosa* PAO1 was grown overnight in LB liquid culture, cells were spun down and resuspended in PBS. Flagella were sheared off the cells by passing the suspension through a 23 gauge needle approximately 25 times. After centrifugation, the supernatant containing flagella was concentrated, proteins separated by SDS-PAGE and analyzed by Western blot using anti-FliD scFv-Fc SH1579-B7 and an anti-human-IgG-HRP conjugate secondary antibody.

Generation of anti-FliD antibodies {#s4-16}
----------------------------------

Human antibodies were generated as described by [@bib17]. In brief, recombinant head region only FliD~78﻿--273~ was immobilized on Costar High Binding plates and incubated with the Hyperphage packaged human antibody gene libraries HAL9/10 ([@bib32]) for negative selection. The non-binding scFv phages were incubated with recombinant full-length FliD~1﻿--474~ to select binders specific for the leg region of FliD. In total, three panning rounds were performed and monoclonal antibodies were identified as described by [@bib17]. The antibody SH1579-B7 was recloned as an scFv-Fc (Yumab) with a human IgG1 Fc region and produced in mammalian cell culture as described by [@bib26].

Intrinsic disorder {#s4-17}
------------------

The sequence of the full-length FliD was submitted to twelve publicly available servers implementing different algorithms for protein disorder prediction. In all cases, we used the default parameters. The servers used were as follows: disEMBL ([@bib35]), GlobProt ([@bib36]), IUPred ([@bib13]), RONN ([@bib62]), DisPro ([@bib10]), PONDR ([@bib45]), Spine-D ([@bib65]), OnD-CRF ([@bib59]), Foldindex ([@bib44]), MFDp ([@bib41]), MFDp2 ([@bib41]), and MD2 ([@bib30]). Averaging of the results gave all servers equal weight.

Accession code {#s4-18}
--------------

Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 5FHY.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Bacterial flagellar capping proteins adopt diverse oligomeric states\" for consideration by *eLife*. Your article has been favorably evaluated by Richard Losick (Senior Editor) and three reviewers, one of whom, Richard M Berry (Reviewer \#1), is a member of our Board of Reviewing Editors. The following individuals involved in review of your submission have agreed to reveal their identity: Keiichi Namba (Reviewer \#2) and Gillian Fraser (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

All reviewers agree that the findings are important and suitable for publication in *eLife*. However, one major point of concern remains: whether the hexameric form is biologically relevant in the full-length FliD, rather than a consequence of the loss of the D0 domain.

Before the paper can be accepted for publication, the authors should present solid experimental evidence that the hexameric complex is really the physiological form of the filament cap of *Pseudomonas* flagella. This might best be achieved if the authors could show hexamers of full-length FliD by negative stain EM and class averaging, as they have done for the FliD~78-405~ truncate.

The individual reviewers\' reports are included below. The authors should also address the reviewers\' points in detail.

Reviewer \#1:

The presentation of the atomic structure of the hexameric fragment of FliD, with its similarities in fold to other flagellar components but different symmetry to the pentameric FliD of *Salmonella* make this paper interesting and important.

Minor comments:

1\) Introduction: Chain mechanism is controversial. Acknowledge that and cite instead -- Trends Microbiol. 2015 May;23(5):296-300. Fueling type III secretion. Lee PC, Rietsch A. Or omit entirely (see reviewer \#2, comment 2).

2\) In the last paragraph of the subsection "FliD from *P. aeruginosa* PAO1 forms a hexamer": Where does the finding of a Tetramer by analytic ultracentrifugation in the full-length protein fit in the model? Present evidence of a hexamer in the full-length protein.

3\) In the subsection "Multiple regions of FliD interact with one another": show a model of a full-length monomer and relate this to the native state.

4\) In the first paragraph of the Discussion: Is this the most likely solution? The *Salmonella* filament has 5, 6 and 11-start helices, so could just as easily accommodate 6 as 5? (See also reviewer \#3, comment 1).

5\) In the first paragraph of the Discussion: Compare to \"domain-swap\" model of FliG -- Domain-swap polymerization drives the self-assembly of the bacterial flagellar motor. Baker MA et al. Nat Struct Mol Biol. 2016 Mar;23(3):197-203. But given that oligomerization interactions are thought to reside elsewhere, are these also domain-swapped? Any evidence to this, or too much missing structure?

Reviewer \#2:

This paper describes the structural study of *Pseudomonas* FliD by X-ray crystallography and biophysical analyses by multiple methods. FliD is a protein that forms the cap complex at the distal end of the bacterial flagellar filament for the promotion of filament assembly by many copies of flagellin exported from the cytoplasm. The filament does not form in the absence of the FliD cap. This study presents the first high-resolution structure of FliD from any bacterial species. It also describes the hexameric complex structure, which is in contrast with the pentameric complex formed by *Salmonella* FliD, and the intermolecular interactions involved in the hexameric state. The authors discuss the implication of the difference in the stoichiometry between bacterial species.

Minor comments:

1\) Abstract: Phrases such as \"regulates assembly\" and \"Without FliD, flagella are improperly constructed\" do not appropriately describe the FliD function because the flagella are not formed at all in the absence of FliD.

2\) Introduction: Many people have expressed doubt on the validity of the chain mechanism proposed by Evans et al. 2013, partly because of the presence of solid data of an exponential decay in the flagellar growth rate by Iino 1974. In any case the chain mechanism is irrelevant to this study.

3\) In the subsection "Crystal structure of the FliD protein from *P. aeruginosa* PAO1" the third sentence from the end is a bit difficult to follow.

4\) In the second paragraph of the Discussion: Although FlgK binds directly to the distal end of the hook, it is not the hook capping protein but is a junction protein that connects the hook and filament.

5\) In the subsection "Analytical Ultracentrifugation": Use of a program Sedfit is recommended for the data analysis of analytical ultracentrifugation.

6\) [Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}: Domain labels of Head 1 and Head 2 for model figures would help readers to identify them.

7\) [Figures 3](#fig3){ref-type="fig"}--[5](#fig5){ref-type="fig"}: The units of q and r are all missing.

8\) [Figure 6C: A](#fig6){ref-type="fig"} description of the color code is missing.

9\) [Figure 7](#fig7){ref-type="fig"}: Since there are five panels in (A), it is difficult to identify which are \"above\", \"below\", and \"right\". There is no figure (C).

Reviewer \#3:

Sandra Postel and colleagues present the atomic structure of a major central fragment of *Pseudomonas aeruginosa* FliD, the capping protein for the flagellar filament. This first high-resolution structure of FliD reveals that the cap monomer, which oligomerises to form an annular structure, shows unexpected structural similarity to the axial components of the flagellum, which polymerise to form hollow helical structures. These novel findings are the major strengths of the manuscript.

The FliD~78-405~ truncate packs as a hexamers and dodecamers in the crystal lattice, and the authors go on to show that these hexameric and dodecameric forms are also found in solution, as shown by negative stain EM class averaging. This finding is supported by data from AUC and crosslinking (the SAXS data support formation of a hollow sphere that is not at odds with the dodecameric form). The physiologically relevant hexameric form of *Pseudomonas* FliD is different from the *Salmonella* FliD pentamer observed by Namba and colleagues using a range of methods, including cryo-EM.

1\) My main concern is that the hexameric form of *Pseudomonas* FliD might be an artifact caused by truncation of the termini (residues 1-77 and 406-474), removing the flexible D0 domains so critical to FliD oligomerization. The authors do perform AUC and crosslinking with full-length *Pseudomonas* FliD that demonstrate formation of higher order oligomers, but I\'m not convinced that these data support the proposal that the hexamer or dodecamer are the predominant forms. I would be more convinced if the authors could show hexamers of full-length FliD by negative stain EM and class averaging, as they have done for the FliD~78-405~ truncate.

A couple of published findings about the *Pseudomonas* flagellar cap and filament further increase my doubts about the physiological relevance of the FliD hexamer. The first is the finding by Aizawa and colleagues that *Pseudomonas* fliD, when expressed in trans, can complement the filament assembly defect of the *Salmonella* fliD null strain (Exchangeability of the flagellin (FliC) and the cap protein (FliD) among different species in flagellar assembly. Inaba S, Hashimoto M, Jyot J, Aizawa S. (2013) Biopolymers. 99(1):63-72. doi: 10.1002/bip.22141). The second is the finding by Trachtenberg and colleagues that the flagellar filament of *Pseudomonas r*hodos appears to have 11-fold symmetry, similar to the *Salmonella* filament (The axial α-helices and radial spokes in the core of the cryo-negatively stained complex flagellar filament of *Pseudomonas* rhodos: recovering high-resolution details from a flexible helical assembly. Cohen-Krausz S, Trachtenberg S. (2003) J Mol Biol 331(5):1093-108).

In my view, stronger data on the oligomeric form of full-length *Pseudomonas* FliD is required.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Bacterial flagellar capping proteins adopt diverse oligomeric states\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Richard Losick (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) The experiment demonstrating that *Salmonella* FliD fails to complement *Pseudomonas* is a suitable response to a comment of reviewer \#3. Without mention of this comment it still warrants inclusion in the text, but the statement of the motivation for the experiment (subsection "FliD from *P. aeruginosa* PAO1 forms a hexamer", last paragraph) is too strong. As written, this calls into doubt the new result of [Figure 4](#fig4){ref-type="fig"}, which answers the reviewers\' main objection to the original manuscript. Please either explain how a pentameric *Pseudomonas* FliD might be compatible with [Figure 4](#fig4){ref-type="fig"}, or remove this statement.

2\) Please acknowledge that there are many possible reasons other than oligomeric state that might explain the inability of *Salmonella* FliD to complement *Pseudomonas*.

10.7554/eLife.18857.025

Author response

All reviewers agree that the findings are important and suitable for publication in eLife. However, one major point of concern remains: whether the hexameric form is biologically relevant in the full-length FliD, rather than a consequence of the loss of the D0 domain.

Before the paper can be accepted for publication, the authors should present solid experimental evidence that the hexameric complex is really the physiological form of the filament cap of Pseudomonas flagella. This might best be achieved if the authors could show hexamers of full-length FliD by negative stain EM and class averaging, as they have done for the FliD~78-405~ truncate.

Reviewer \#1:

Minor comments:

*1) Introduction: Chain mechanism is controversial. Acknowledge that and cite instead -- Trends Microbiol. 2015 May;23(5):296-300. Fueling type III secretion. Lee PC, Rietsch A. Or omit entirely (see reviewer \#2, comment 2).*

We have removed the sentence that refers to the chain mechanism.

*2) In the last paragraph of the subsection "FliD from P. aeruginosa PAO1 forms a hexamer": Where does the finding of a Tetramer by analytic ultracentrifugation in the full-length protein fit in the model? Present evidence of a hexamer in the full-length protein.*

In the absence of the flagellar filament, full-length FliD from *Pseudomonas* PAO1 does not predominate as stable hexamers. We have shown that the hexamer is formed in crosslinking experiments and by AUC, but only a small fraction of the total protein actually forms a hexamer. By crosslinking, we can detect monomeric, dimeric, trimeric, tetrameric, pentameric and hexameric species; by AUC analysis of highly concentrated FliD solutions, we detect tetrameric and hexameric species, predominantly. It is possible that the tetramer may be some form of stable intermediate on the path to hexamers, but we do not have enough data to say this unequivocally. Despite the lack of stability of the *Pseudomonas* FliD hexamer, we previously (prior to submission of the original manuscript, in fact) attempted to perform negative-stain EM using both crosslinked FliD~1-474~ and native FliD~1-474~ at low pH, in the hopes that we could detect larger particles. Unfortunately, we were unsuccessful in this regard. The tendency of *Pseudomonas* FliD to oligomerize is much less than that of *Salmonella* FliD, for which the equilibrium state in solution, even in the absence of the flagellar filament, is almost entirely decameric, as previously shown by crosslinking and AUC analyses conducted by others (and confirmed by us -- data not shown).

Regardless of whether we could visualize the *Pseudomonas* FliD hexamer or not in solution at low resolution by negative-stain EM, we contend that this experiment would not conclusively show that the hexamer was the bona fide functional unit. To show this, we would have to show that *Pseudomonas* FliD acts as a hexamer in vivo, which we have done in a series of additional experiments shown in a new [Figure 4](#fig4){ref-type="fig"}. These experiments are briefly summarized, as follows. We designed, based on our crystal structure, disulfide bonds in full-length *Pseudomonas* FliD that results in a stable FliD hexamer under non-reducing conditions, which we showed by SDS-PAGE, mass spectrometry and SAXS. We then complemented a △*fliD Pseudomonas* strain with the full-length disulfide-constrained *fliD~1-474(I167C/D253C)~* gene, which we tested for swimming motility in a functional assay. This complemented strain restored the swimming motility that was lost in the △*fliD* strain, in a way indistinguishable to that of a full-length wildtype complement (△*fliD/fliD~1-474~*). We isolated flagella from the live, growing △*fliD/fliD~1-474(I167C/D253C)~ Pseudomonas* bacteria and showed by Western blot analysis that the FliD~1-474(I167C/D253C)~ protein remained hexameric in these flagella that provided swimming motility to the bacteria. We therefore conclude that FliD from *Pseudomonas* is functional in a disulfide-locked, hexameric state. Because the disulfide bond was formed between neighboring head regions, these data also indicate that flexibility of the head domains, or at least their relative repositioning, is not required for FliD capping function. In contrast, we found in a similar set of genetic and functional experiments that *Salmonella* FliD cannot complement a △*fliD Pseudomonas* strain and does not restore swimming motility, additional evidence that FliD in a pentameric state is incompatible with *Pseudomonas* flagella formation.

*3) In the subsection "Multiple regions of FliD interact with one another": show a model of a full-length monomer and relate this to the native state.*

We have added a model of what our data suggests the full-length monomer structure is (see [Figure 8D](#fig8){ref-type="fig"}). This model is based on the following data: (i) our crystal structure indicating the atomic positions of FliD residues 78-273 ([Figure 1B](#fig1){ref-type="fig"}); (ii) the likely interfacing regions from those domains that are not modeled in our crystallographic model or missing from the fragment that we crystallized, including the foot, N-terminal coiled coil and C-terminal coiled coil domains, as indicated by our HDX-MS data ([Figure 8C](#fig8){ref-type="fig"}); and (iii) the SAXS molecular envelope that we generated for the disulfide-linked hexamer ([Figure 4C](#fig4){ref-type="fig"}). We believe that this model of the monomer reflects its native "resting" state, that is, the structure of the monomer in the absence of the flagellar filament or of a FliD monomer subunit on the distal end of the flagellar filament that is not actively chaperoning and sorting a FliC protein subunit. The dynamic nature of FliD suggests that FliD monomers within the cap oligomer will adopt a different structure(s) when chaperoning and sorting FliC subunits, which our data does not inform and that we believe is beyond the scope of this paper.

*4) In the first paragraph of the Discussion: Is this the most likely solution? The Salmonella filament has 5, 6 and 11-start helices, so could just as easily accommodate 6 as 5? (See also reviewer \#3, comment 1).*

Yes, all of our data indicates that *Pseudomonas* FliD oligomerizes as a hexamer in crystals, in solution and in vivo (see response to reviewer \#1, comment \#2). No evidence exists that *Salmonella* FliD ever adopts any form other than a pentamer (except when it forms a decamer in the absence of the flagellar filament) and, likewise, there is no evidence that *Pseudomonas* FliD exists in a state other than a hexamer in vivo.

*5) In the first paragraph of the Discussion: Compare to \"domain-swap\" model of FliG -- Domain-swap polymerization drives the self-assembly of the bacterial flagellar motor. Baker MA et al. Nat Struct Mol Biol. 2016 Mar;23(3):197-203. But given that oligomerization interactions are thought to reside elsewhere, are these also domain-swapped? Any evidence to this, or too much missing structure?*

We have shown that *Pseudomonas* FliD oligomerization is not driven by interactions between the head domains. Accordingly, "domain-swapping" between head domains cannot be the driving force for self-assembly. Also, by locking full-length FliD in a hexameric state with disulfide bonds between neighboring head domains, the protein remains functional and complements △*fliD* strains in swimming motility assays. Therefore, it is also unlikely that domain-swap polymerization between the head domains plays any functional role. Without high-resolution structural information for the other flexible regions of FliD that do drive self-assembly, though, it is possible that domain-swaps occur between these other domains. Such a domain-swap molecular mechanism within these other regions outside of the head region may contribute, in part or in whole, to FliD self-assembly. However, with such an extent of missing structure, we have no evidence of this at this time.

Reviewer \#2:

*Minor comments:*

*1) Abstract: Phrases such as \"regulates assembly\" and \"Without FliD, flagella are improperly constructed\" do not appropriately describe the FliD function because the flagella are not formed at all in the absence of FliD.*

This has been altered accordingly in text.

*2) Introduction: Many people have expressed doubt on the validity of the chain mechanism proposed by Evans et al. 2013, partly because of the presence of solid data of an exponential decay in the flagellar growth rate by Iino 1974. In any case the chain mechanism is irrelevant to this study.*

This sentence has been removed (see comment to reviewer \#1, comment \#1).

*3) In the subsection "Crystal structure of the FliD protein from P. aeruginosa PAO1" the third sentence from the end is a bit difficult to follow.*

We have split this long, difficult to follow sentence into two sentences, which now reads:

"Both analyses indicated that the crystals consisted of an approximate 50:50 mixture of the FliD~78-405~ protein used for crystallization and a further proteolyzed version with a molecular weight of about 27 kDa. The N-terminal His~6~-tag is still detectable by Western blot indicating that proteolysis occurred from the C-terminus ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"})."

*4) In the second paragraph of the Discussion: Although FlgK binds directly to the distal end of the hook, it is not the hook capping protein but is a junction protein that connects the hook and filament.*

This has been updated in text.

*5) In the subsection "Analytical Ultracentrifugation": Use of a program Sedfit is recommended for the data analysis of analytical ultracentrifugation.*

We used DC/DT+, which generally performs as well as SedFit in analysis of sedimentation velocity data, to analyze our data. We used SedFit to analyze some of the data and obtained results essentially identical to those we obtained using DC/CT+. Since we found no difference in the analyses, we have not changed the description of how we handled the data in the text.

*6) [Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}: Domain labels of Head 1 and Head 2 for model figures would help readers to identify them.*

Domain labels have been added to [Figures 1](#fig1){ref-type="fig"} and 2.

*7) [Figures 3](#fig3){ref-type="fig"}--[5](#fig5){ref-type="fig"}: The units of q and r are all missing.*

The units of q and r have now been added to these figures.

*8) [Figure 6C: A](#fig6){ref-type="fig"} description of the color code is missing.*

A description of the color code has been added to [Figure 7](#fig7){ref-type="fig"} (formerly [Figure 6](#fig6){ref-type="fig"}). The color code in [Figure 7C](#fig7){ref-type="fig"} is the same as in [Figure 7A](#fig7){ref-type="fig"}, which has been added to legend.

*9) [Figure 7](#fig7){ref-type="fig"}: Since there are five panels in (A), it is difficult to identify which are \"above\", \"below\", and \"right\". There is no figure (C).*

[Figure 8D](#fig8){ref-type="fig"} (formerly [Figure 7C](#fig7){ref-type="fig"}) has been added. We also added a new [Figure 8B](#fig8){ref-type="fig"} in an attempt to avoid some of the confusion caused by our previous labeling scheme.

Reviewer \#3:

*1) My main concern is that the hexameric form of Pseudomonas FliD might be an artifact caused by truncation of the termini (residues 1-77 and 406-474), removing the flexible D0 domains so critical to FliD oligomerization. The authors do perform AUC and crosslinking with full-length Pseudomonas FliD that demonstrate formation of higher order oligomers, but I\'m not convinced that these data support the proposal that the hexamer or dodecamer are the predominant forms. I would be more convinced if the authors could show hexamers of full-length FliD by negative stain EM and class averaging, as they have done for the FliD~78-405~ truncate.*

A couple of published findings about the Pseudomonas flagellar cap and filament further increase my doubts about the physiological relevance of the FliD hexamer. The first is the finding by Aizawa and colleagues that Pseudomonas fliD, when expressed in trans, can complement the filament assembly defect of the Salmonella fliD null strain (Exchangeability of the flagellin (FliC) and the cap protein (FliD) among different species in flagellar assembly. Inaba S, Hashimoto M, Jyot J, Aizawa S. (2013) Biopolymers. 99(1):63-72. doi: 10.1002/bip.22141). The second is the finding by Trachtenberg and colleagues that the flagellar filament of Pseudomonas rhodos appears to have 11-fold symmetry, similar to the Salmonella filament (The axial α-helices and radial spokes in the core of the cryo-negatively stained complex flagellar filament of Pseudomonas rhodos: recovering high-resolution details from a flexible helical assembly. Cohen-Krausz S, Trachtenberg S. (2003) J Mol Biol 331(5):1093-108).

Full-length *Pseudomonas* FliD is not stable enough to perform negative stain EM and class averaging as we did with the FliD~78-405~ fragment for which we also solved the crystal structure. Instead, we have shown that the hexameric form of *Pseudomonas* FliD is functional in vivo, a more rigorous and realistic test of whether the hexameric state is not simply an artifact caused by truncation or other manipulation of the protein.

We have carefully reviewed the Inaba et al. paper to which the reviewer refers. We conclude that the authors of this paper have incorrectly interpreted their data. While it is clear from their data that *Salmonella* and *E. coli* FliC and FliD can be exchanged (see Figures 2A, 3A, 4A and 7A), it is equally clear that *Salmonella* and *Pseudomonas* FliC as well as FliD cannot be exchanged to produce functional flagella. For instance, there is clearly no difference in Figure 2B, spots \#3 (*Salty* △*fliC* mutant (SJW2536)), \#4 (*Salty* △*fliC* mutant transduced with p*Pseae* (PAO1) *fliC*). \#5 (*Salty* △*fliC* mutant p*Pseae* (PAK) *fliC*), \#6 (*Salty* △*fliD* mutant (MH43)), and\#7 (*Salty* △*fliD* mutant transduced with p*Pseae* (PAO1) *fliD*). None of these strains exhibit swarming motility in this assay, whereas wildtype *Pseae* (PAK) and *Pseae* (PAO1) strains do exhibit swarming motility, as seen in Figure 2B, spots \#1 and \#2, respectively. Likewise, the electron microscopic evidence is non-existent for functional FliC and FliD exchange between *Salmonella* and *Pseudomonas*. In Figure 5A, panels \#2 (*Salty* △*fliC* mutant transduced with p*Pseae* (PAO1) *fliC*) and \#3 (*Salty* △*fliC* mutant transduced with p*Pseae* (PAK) *fliC*) do not show functional flagella. Similarly, appendages shown in Figure 8A (*Salty* △*fliD* mutant transduced with p*Pseae* (PAO1) *fliD*) look nothing like fully formed wildtype flagella. These short, stubby appendages do not resemble the functional flagella shown in other electron micrographs in this paper (e.g., of wildtype bacteria strains), but could possibly be flagella formed up to the hook, which would fit with non-exchangeability of these FliC and also FliD proteins (although we do not have access to enough of their data to say this with any certainty). Finally, in Figure 9C, the double complementation (*Salty* △*fliC* △*fliD* mutant transduced with both p*Pseae* (PAO1) *fliC* and p*Pseae* (PAO1) *fliD* together) exhibit absolutely no appendages that could be (mis)construed as flagella. It is unclear to us how Inaba et al. could interpret these data to conclude that *Salmonella* and *Pseudomonas* FliD are functionally exchangeable.

We took the additional step of testing this concept ourselves. We asked whether *Pseudomonas* FliD could be functionally exchanged with *Salmonella* FliD, using wildtype *Pseudomonas*, a △*fliD* mutant *Pseudomonas* strain, and the same △*fliD* mutant *Pseudomonas* strain complemented with *Salmonella fliD* -- essentially a repetition of the Inaba et al. experiments but in the reverse knock-out/complementation direction. In our swimming motility assay, we found that the latter (△*fliD/fliD~StyFliDe~*) strain was completely non-functional in this assay (see [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"} in our revised manuscript). These data agree with our re-interpretation of Inaba et al.'s data and indicate that, indeed, *Salmonella* FliD (a pentamer) cannot be functionally exchanged with *Pseudomonas* FliD (a hexamer).

We have also revisited the Cohen-Krausz & Trachtenberg paper mentioned by the reviewer. Well prior to the publication of this paper in 2003, *Pseudomonas rhodos* had been renamed *Methylobacterium rhodinum*. These bacteria diverge at the class level -- the former belongs to the class of Gammaproteobacteria and the latter to Alphaproteobacteria. No genomic sequence data is available for this bacterium and no gene or protein sequence from it appears when we conduct a BLAST search using the *Pseudomonas fliD* gene or FliD protein sequences. Thus, we do not believe that this bacterium and whatever morphology their flagella may or may not adopt is relevant to our studies.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) The experiment demonstrating that Salmonella FliD fails to complement Pseudomonas is a suitable response to a comment of reviewer \#3. Without mention of this comment it still warrants inclusion in the text, but the statement of the motivation for the experiment (subsection "FliD from P. aeruginosa PAO1 forms a hexamer", last paragraph) is too strong. As written, this calls into doubt the new result of [Figure 4](#fig4){ref-type="fig"}, which answers the reviewers\' main objection to the original manuscript. Please either explain how a pentameric Pseudomonas FliD might be compatible with [Figure 4](#fig4){ref-type="fig"}, or remove this statement.

We have removed the statement of the motivation for the experiment, which we agree was too strong and confusing. The paragraph now starts "We also test whether *Salmonella* FliD...".

2\) Please acknowledge that there are many possible reasons other than oligomeric state that might explain the inability of Salmonella FliD to complement Pseudomonas.

We have acknowledged this by adding to the following sentence to the end of the paragraph describing these experiments, which reads: "Although there exist many possible reasons other than oligomeric state that could explain the inability of *Salmonella* FliD to functionally complement *Pseudomonas*, these data suggest that *Pseudomonas* flagella may prefer FliD proteins that adopt hexameric rather than pentameric states."
